VivoSim Labs, Inc. (VIVS) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by VivoSim Labs, Inc. on May 6, 2025, covering events reported as of April 30, 2025. The filing addresses the Company's status regarding Nasdaq continued listing requirements following prior notices of non-compliance.
Key Financial Metrics
The filing references historical financial data from the Quarterly Report on Form 10-Q for the period ended December 31, 2024, which reported stockholders' equity of $364,000. This amount was below the Nasdaq Listing Rule 5550(b)(1) requirement of $2,500,000. The filing does not provide current revenue, profit, cash flow, or debt figures for the period ending April 30, 2025.
Material Changes and Compliance Status
- Previous Non-Compliance: On February 19, 2025, Nasdaq notified the Company of non-compliance with the minimum stockholders' equity requirement. On January 16, 2025, the Company was also notified of non-compliance with the minimum bid price of $1.00 per share.
- Hearing Outcome: The Company requested a hearing before the Nasdaq Hearings Panel, presenting a compliance plan on February 27, 2025. On March 27, 2025, the Panel granted an exception until April 15, 2025, to demonstrate compliance.
- Current Status: On April 30, 2025, Nasdaq notified the Company that it has successfully demonstrated compliance with both the minimum bid price (Rule 5550(a)(2)) and minimum stockholders' equity (Rule 5550(b)(1)) requirements.
Outlook, Risks, and Contingencies
As a condition of regaining compliance, the Company is subject to a Mandatory Panel Monitor for a period of one year from April 30, 2025, pursuant to Nasdaq Listing Rule 5815(d)(4)(B). The filing includes standard forward-looking statements, noting that there is no assurance the Company will continue to maintain compliance with applicable Nasdaq listing requirements in the future.
Investor Verification Checklist
- Verify the specific actions taken by the Company to increase stockholders' equity from $364,000 to the required $2,500,000 threshold.
- Confirm the current trading price of VIVS to ensure it remains above the $1.00 minimum bid price.
- Review the Company's upcoming periodic reports (10-Q or 10-K) for updated financial statements reflecting the capitalization changes made to achieve compliance.
- Monitor the Company's status during the one-year Mandatory Panel Monitor period for any further compliance warnings.